BC
TNDM icon

Bridgefront Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bridgefront Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
+10,844
New +$189K 0.04% 468
2025
Q3 		– Sell
-18,278
Closed -$341K – 836
2025
Q2 		$341K Buy
18,278
+514
+3% +$10.2K 0.09% 390
2025
Q1 		$340K Buy
+17,764
New +$520K 0.1% 364
2021
Q3 		– Sell
-6,907
Closed -$673K – 655
2021
Q2 		$673K Buy
+6,907
New +$616K 0.25% 107

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Bridgefront Capital's TNDM Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 10,844 shares worth $164K. The stake represents 0.04% of the portfolio and ranks #468 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in TNDM as recently as Q2 2025.

Bridgefront Capital first reported a position in TNDM in Q2 2021 and has held it in 4 quarters since. The position peaked at $673K in Q2 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Bridgefront Capital held 10,844 shares of Tandem Diabetes Care worth $164K as of Q2 2026.
  • Tandem Diabetes Care was a new Bridgefront Capital position in Q2 2026.
  • Tandem Diabetes Care made up 0.04% of Bridgefront Capital's portfolio in Q2 2026, its #468 holding.
  • Bridgefront Capital first reported a position in Tandem Diabetes Care in Q2 2021 and has held it in 4 quarters since.
  • Bridgefront Capital's Tandem Diabetes Care position peaked at $673K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.